Delivery Order SPE2D018D0006-SPE2D026F0105
- Not listed
- This federal contract award to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, is a delivery order from the Defense Logistics Agency Troop Support Medical. The contract is for the supply of 250mg vials of the drug Ryanodex, with a firm fixed price of $1,693.54 and a completion date of January 5, 2024. The place of performance is Westwood, New Jersey. This delivery order is part of a larger Federal Supply Schedule contract held by Eagle Pharmaceuticals through the...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the delivery of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract has a ceiling value of $5,292.66 and a period of performance ending on February 10, 2025. This contract is part of a larger Federal...
- The Defense Logistics Agency issued a $4,803.21 delivery order to Amerisourcebergen Drug Corp on February 3, 2026, for Ryanodex 250 mg vials, with ultimate completion by February 25, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which supports pharmaceutical procurement for military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Ryanodex 250 mg vials with a ceiling value of $41,627.82. The order was issued under the DLA Troop Support Medical indefinite delivery contract SPE2DX, a $999,999,999 vehicle running through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed-price...
- The Defense Logistics Agency awarded a $9,606.42 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Ryanodex 250 mg vials, with performance completion scheduled for February 5, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The work will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,246.72 Firm Fixed Price Delivery Order is for the supply of RYANODEX 250 MG VIALS, with a completion date of December 18, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,623.36 Firm Fixed Price delivery order covers the supply of RYANODEX 250 MG VIALS, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency issued a $16,010.70 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Ryanodex 250 mg vials, with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, Pennsylvania....
- SPE2D018D0006Indefinite Delivery Contract
- SPE2D018D0006-SPE2D026F0105Delivery Order
The Medical Supply Chain division of the Department of Defense issued a $185,585.74 delivery order to Eagle Pharmaceuticals, Inc. on February 26, 2026, for pharmaceutical supply through its Federal Supply Schedule contract with the Veterans Integrated Service Network 12. Place of performance is Westwood, NJ. The order is firm fixed price with an ultimate completion date of April 6, 2027. Eagle Pharmaceuticals specializes in critical injectable medications, including Ryanodex 250 mg vials for malignant hyperthermia treatment. The parent Federal Supply Schedule contract, valued at $30.89 million and expiring January 31, 2029, covers drugs, pharmaceuticals, and hematology products under Federal Supply Classification 65 I B and enables procurement by both VISN 12 and the Defense Logistics Agency Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $185.6k | 2/25/26 |